Ó³»­´«Ã½

J.T. Neal is the co-director of type 2 diabetes systems genomics at the Ó³»­´«Ã½ of MIT and Harvard, where he is also an institute scientist. He is also an investigator in the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease at the Ó³»­´«Ã½. The Neal lab develops and applies novel technologies for genome editing as well as massively parallel single-cell imaging and transcriptomics approaches for studying the effects of genetic variation in cancer, diabetes, and other diseases. 

Neal received his B.S. in biochemistry from the University of Washington and his Ph.D. from the University of Oregon, where he studied host-microbe interactions during development and tumorigenesis. He completed postdoctoral training as an American Cancer Society fellow at Stanford University, where he developed new organoid culture and single-cell sequencing methods for the study of tumor immunology. Neal is a recipient of a Merkin Institute Fellowship and a 2021 NIH Director’s New Innovator Award.